en
Connect Learn Finance

Redirect notice

You are being redirected to the platform Enko where you can access 100% free resources to boost your business. This is a collaboration between Visa and Connectamericas for Women.
Home > Companies > 89Bio
Company

89Bio

To rate this company
Israel
11-50 employees
Established in 2018

Company description

See translation

89bio is a clinical-stage biopharmaceutical company focused on nonalcoholic steatohepatitis and other liver and metabolic disorders. The company's lead product candidate is BIO89-100, a novel long-acting glycopegylated fibroblast growth factor 21 analogue.
IndustrySector / Industry
{{industry.name}}
Products and ServicesProducts and Services
{{pas.productName}}
HS code: {{pas.hsCode | limitTo: 23}}
Show more

Commercial information

Affiliations:

Start-Up Nation Central

Badges

These badges certify that certain information declared by a company has been verified, so it can increase the reliability and visibility of its profile.

Find out more!
Company verified byConnectAmericas
What does this badge mean?

ConnectAmericas has verified this company is legally constituted and the people linked to this enterprise are able to do businesses.

Request it!
Find out more about the Badges in ConnectAmericas
This information is provided by Start-Up Nation Finder Click here to see more

Contact information

To see this content

People in this company (1)

Other users also viewed

Loading...

Sign In to ConnectAmericas

Forgot your password? -  Don't have an account? Register here

By creating an account with ConnectAmericas you are accepting
the Privacy Policy and the Terms and Conditions

Enter the e-mail you used when you registered for ConnectAmericas to create a new password